Prenatal inflammation, infections and mental disorders

Psychopathology

Volumn 49, Issue 5, 2016, Pages 317-333

  Flinkkilä, Eerika ^a   Keski Rahkonen, Anna ^a   Marttunen, Mauri ^b,c   Raevuori, Anu ^a,c,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

Infection; Inflammation; Mental disorders; Prenatal exposure delayed effects; Review

Indexed keywords

ANOREXIA NERVOSA; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FEMALE; HUMAN; INFLAMMATION; MENTAL DISORDERS; MOOD DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE; RISK FACTOR; SCHIZOPHRENIA;

ANOREXIA NERVOSA; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FEMALE; HUMANS; INFLAMMATION; MENTAL DISORDERS; MOOD DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SCHIZOPHRENIA;

EID: 84991661903     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000448054     Document Type: Review

References (111)

1. Mednick SA, Machon RA, Huttunen MO, Bonett D: Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988; 45: 189-192.
2. O'Callaghan E, Sham P, Takei N, Glover G, Murray RM: Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet 1991; 337: 1248-1250.
3. Kunugi H, Nanko S, Takei N, Saito K, Hayashi N, Kazamatsuri H: Schizophrenia following in utero exposure to the 1957 influenza epidemics in Japan. Am J Psychiatry 1995; 152: 450-452.
4. Izumoto Y, Inoue S, Yasuda N: Schizophrenia and the influenza epidemics of 1957 in Japan. Biol Psychiatry 1999; 46: 119-124.
5. Takei N, Sham PC, O'Callaghan E, Murray GK, Glover G, Murray RM: Prenatal exposure to influenza and the development of schizophrenia: is the effect confined to females? Am J Psychiatry 1994; 151: 117-119.
6. Sham PC, O'Callaghan E, Takei N, Murray GK, Hare EH, Murray RM: Schizophrenia following prenatal exposure to influenza epidemics between 1939 and 1960. Br J Psychiatry 1992; 160: 461-466.
7. McGrath JJ, Pemberton MR, Welham JL, Murray RM: Schizophrenia and the influenza epidemics of 1954, 1957 and 1959: a southern hemisphere study. Schizophr Res 1994; 14: 1-8.
8. Takei N, Mortensen PB, Klaening U, Murray RM, Sham PC, O'Callaghan E: Relationship between in utero exposure to influenza epidemics and risk of schizophrenia in Denmark. Biol Psychiatry 1996; 40: 817-824.
9. Limosin F, Rouillon F, Payan C, Cohen JM, Strub N: Prenatal exposure to influenza as a risk factor for adult schizophrenia. Acta Psychiatr Scand 2003; 107: 331-335.
10. Barr CE, Mednick SA, Munk-Jorgensen P: Exposure to influenza epidemics during gestation and adult schizophrenia. Arch Gen Psychiatry 1990; 47: 869-874.
11. Takei N, van Os J, Murray RM: Maternal exposure to influenza and risk of schizophrenia: a 22-year study from the Netherlands. J Psychiatr Res 1995; 29: 435-445.
12. Adams W, Kendell RE, Hare EH, Munk-Jørgensen P: Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia. Br J Psychiatry 1993; 163: 522-534.
13. Kendell RE, Kemp IW: Maternal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 1989; 46: 878-882.
14. Selten JP, Slaets JP, Kahn RS: Prenatal exposure to influenza and schizophrenia in Surinamese and Dutch Antillean immigrants to The Netherlands. Schizophr Res 1998; 30: 101-103.
15. Susser ES, Lin SP, Brown AS, Lumey LH, Erlenmeyer-Kimling L: No relation between risk of schizophrenia and prenatal exposure to influenza in Holland. Am J Psychiatry 1994; 151: 922-924.
16. Selten JP, Brown AS, Moons KG, Slaets JP, Susser ES, Kahn RS: Prenatal exposure to the 1957 influenza pandemic and non-Affective psychosis in The Netherlands. Schizophr Res 1999; 38: 85-91.
17. Selten JP, Slaets JP: Evidence against maternal influenza as a risk factor for schizophrenia. Br J Psychiatry 1994; 164: 674-676.
18. Erlenmeyer-Kimling L, Folnegovic Z, Hrabak-Zerjavic V, Borcic B, Folnegovic-Smalc V, Susser ES: Schizophrenia and prenatal exposure to the 1957 A2 influenza epidemic in Croatia. Am J Psychiatry 1994; 151: 1496-1498.
19. Morgan V, Castle D, Page A: Influenza epidemics and incidence of schizophrenia, affective disorders and mental retardation in Western Australia: no evidence of a major effect. Schizophr Res 1997; 26: 25-39.
20. Mino Y, Oshima I, Tsuda T, Okagami K: No relationship between schizophrenic birth and influenza epidemics in Japan. J Psychiatr Res 2000; 34: 133-138.
21. Westergaard T, Mortensen PB, Pedersen CB, Wohlfahrt J, Melbye M: Exposure to prenatal and childhood infections and the risk of schizophrenia: suggestions from a study of sibship characteristics and influenza prevalence. Arch Gen Psychiatry 1999; 56: 993-998.
22. Battle YL, Martin BC, Dorfman JH, Miller LS: Seasonality and infectious disease in schizophrenia: the birth hypothesis revisited. J Psychiatr Res 1999; 33: 501-509.
23. O'Callaghan E, Sham PC, Takei N, Murray G, Glover G, Hare EH: The relationship of schizophrenic births to 16 infectious diseases. Br J Psychiatry 1994; 165: 353-356.
24. Venables PH: Schizotypy and maternal exposure to influenza and to cold temperature: the Mauritius study. J Abnorm Psychol 1996; 105: 53-60.
25. Favaro A, Tenconi E, Ceschin L, Zanetti T, Bosello R, Santonastaso P: In utero exposure to virus infections and the risk of developing anorexia nervosa. Psychol Med 2011; 41: 2193-2199.
26. Mednick SA, Huttunen MO, Machon RA: Prenatal influenza infections and adult schizophrenia. Schizophr Bull 1994; 20: 263-267.
27. Cannon M, Cotter D, Coffey VP: Prenatal exposure to the 1957 influenza epidemic and adult schizophrenia: a follow-up study. Br J Psychiatry 1996; 168: 368-371.
28. Brown AS, Schaefer CA, Wyatt RJ, Goetz R, Begg MD, Gorman JM: Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study. Schizophr Bull 2000; 26: 287-295.
29. Babulas V, Factor-Litvak P, Goetz R, Schaefer CA, Brown AS: Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. Am J Psychiatry 2006; 163: 927-929.
30. Sorensen HJ, Mortensen EL, Reinisch JM, Mednick SA: Association between prenatal exposure to bacterial infection and risk of schizophrenia. Schizophr Bull 2009; 35: 631-637.
31. Clarke MC, Tanskanen A, Huttunen M, Whittaker JC, Cannon M: Evidence for an interaction between familial liability and prenatal exposure to infection in the causation of schizophrenia. Am J Psychiatry 2009; 166: 1025-1030.
32. Nielsen PR, Laursen TM, Mortensen PB: Association between parental hospital-treated infection and the risk of schizophrenia in adolescence and early adulthood. Schizophr Bull 2013; 39: 230-237.
33. Suvisaari JM, Taxell-Lassas V, Pankakoski M, Haukka JK, Lonnqvist JK, Hakkinen LT: Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder. Schizophr Bull 2013; 39: 1056-1066.
34. Betts KS, Williams GM, Najman JM, Scott J, Alati R: Maternal prenatal infection, early susceptibility to illness and adult psychotic experiences: a birth cohort study. Schizophr Res 2014; 156: 161-167.
35. Blomström A, Karlsson H, Gardner R, Jörgensen L, Magnusson C, Dalman C: Associations between maternal infection during pregnancy, childhood infections, and the risk of subsequent psychotic disorder-A Swedish cohort study of nearly 2 million individuals. Schizophr Bull 2016; 42: 125-133.
36. Atladóttir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke S, Abdallah M: Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 2010; 40: 1423-1430.
37. Zerbo O, Iosif AM, Walker C, Ozonoff S, Hansen RL, Hertz-Picciotto I: Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (Childhood Autism Risks from Genetics and Environment) study. J Autism Dev Disord 2013; 43: 25-33.
38. Atladóttir HO, Henriksen TB, Schendel DE, Parner ET: Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics 2012; 130:e1447-1454.
39. Mann JR, McDermott S: Are maternal genitourinary infection and pre-eclampsia associated with ADHD in school-Aged children? J Atten Disord 2011; 15: 667-673.
40. Parboosing R, Bao Y, Shen L, Schaefer CA, Brown AS: Gestational influenza and bipolar disorder in adult offspring. JAMA Psychiatry 2013; 70: 677-685.
41. Pang D, Syed S, Fine P, Jones PB: No association between prenatal viral infection and depression in later life-A long-term cohort study of 6,152 subjects. Can J Psychiatry 2009; 54: 565-570.
42. Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V: Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 2004; 161: 889-895.
43. Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M: Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004; 61: 774-780.
44. Brown AS, Schaefer CA, Quesenberry CP Jr, Shen L, Susser ES: No evidence of relation between maternal exposure to herpes simplex virus type 2 and risk of schizophrenia? Am J Psychiatry 2006; 163: 2178-2180.
45. Buka SL, Cannon TD, Torrey EF, Yolken RH; Collaborative Study Group on the Perinatal Origins of Severe Psychiatric Disorders: Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol Psychiatry 2008; 63: 809-815.
46. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH: Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 2001; 58: 1032-1037.
47. Brown AS, Vinogradov S, Kremen WS, Poole JH, Deicken RF, Penner JD: Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. Am J Psychiatry 2009; 166: 683-690.
48. Canetta S, Sourander A, Surcel HM, Hinkka-Yli-Salomaki S, Leiviska J, Kellendonk C: Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort. Am J Psychiatry 2014; 171: 960-968.
49. Brown AS, Sourander A, Hinkka-Yli-Salomaki S, McKeague IW, Sundvall J, Surcel HM: Elevated maternal C-reactive protein and autism in a national birth cohort. Mol Psychiatry 2014; 19: 259-264.
50. Edwards MJ: Hyperthermia in utero due to maternal influenza is an environmental risk factor for schizophrenia. Congenit Anom (Kyoto) 2007; 47: 84-89.
51. Khandaker GM, Zimbron J, Lewis G, Jones PB: Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol Med 2013; 43: 239-257.
52. Mortensen PB, Norgaard-Pedersen B, Waltoft BL, Sorensen TL, Hougaard D, Yolken RH: Early infections of Toxoplasma gondii and the later development of schizophrenia. Schizophr Bull 2007; 33: 741-744.
53. Brown AS: Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 2006; 32: 200-202.
54. Meyer U, Feldon J, Yee BK: A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 2009; 35: 959-972.
55. Meyer U, Feldon J: Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia. Psychopharmacology (Berl) 2009; 206: 587-602.
56. Meyer U, Feldon J: Neural basis of psychosisrelated behaviour in the infection model of schizophrenia. Behav Brain Res 2009; 204: 322-334.
57. Anderson G, Maes M: Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression. Prog Neuropsychopharmacol Biol Psychiatry 2013; 42: 5-19.
58. Ebert T, Kotler M: Prenatal exposure to influenza and the risk of subsequent development of schizophrenia. Isr Med Assoc J 2005; 7: 35-38.
59. Meyer U, Yee BK, Feldon J: The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? Neuroscientist 2007; 13: 241-256.
60. Brown AS, Derkits EJ: Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 2010; 167: 261-280.
61. Patterson PH: Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 2009; 204: 313-321.
62. Brown AS: Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol 2012; 72: 1272-1276.
63. Watson JB, Mednick SA, Huttunen M, Wang X: Prenatal teratogens and the development of adult mental illness. Dev Psychopathol 1999; 11: 457-466.
64. Patterson PH: Maternal infection and immune involvement in autism. Trends Mol Med 2011; 17: 389-394.
65. Selten JP, Frissen A, Lensvelt-Mulders G, Morgan VA: Schizophrenia and 1957 pandemic of influenza: meta-Analysis. Schizophr Bull 2010; 36: 219-228.
66. Lindell AK: On the interrelation between reduced lateralization, schizotypy, and creativity. Front Psychol 2014; 5: 813.
67. Crow TJ, Done DJ, Johnstone EC: Schizophrenia and influenza. Lancet 1991; 338: 116-118.
68. Torrey EF, Bowler AE, Rawlings R: An influenza epidemic and the seasonality of schizophrenic births; in Kurstak E (ed): Second World Congress on Viruses and Mental Health. New York, Plenum, 1991, pp 109-116.
69. Brown AS, Schaefer CA, Quesenberry CP Jr, Liu L, Babulas VP, Susser ES: Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005; 162: 767-773.
70. Mortensen PB, Norgaard-Pedersen B, Waltoft BL, Sorensen TL, Hougaard D, Torrey EF: Toxoplasma gondii as a risk factor for earlyonset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry 2007; 61: 688-693.
71. Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J, Hansen R: Increased midgestational IFN-?, IL-4 and IL-5 in women bearing a child with autism: a case-control study. Mol Autism 2011; 2: 13.
72. Abdallah MW, Larsen N, Grove J, Norgaard-Pedersen B, Thorsen P, Mortensen EL: Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders. World J Biol Psychiatry 2013; 14: 528-538.
73. Fatemi SH, Emamian ES, Kist D, Sidwell RW, Nakajima K, Akhter P: Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry 1999; 4: 145-154.
74. Gilmore JH, Fredrik Jarskog L, Vadlamudi S, Lauder JM: Prenatal infection and risk for schizophrenia: IL-1β, IL-6, and TNFa inhibit cortical neuron dendrite development. Neuropsychopharmacology 2004; 29: 1221-1229.
75. Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M: Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 2006; 59: 546-554.
76. Vuillermot S, Weber L, Feldon J, Meyer U: A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci 2010; 30: 1270-1287.
77. Makinodan M, Tatsumi K, Manabe T, Yamauchi T, Makinodan E, Matsuyoshi H: Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring. J Neurosci Res 2008; 86: 2190-2200.
78. Ducharme G, Lowe GC, Goutagny R, Williams S: Early alterations in hippocampal circuitry and theta rhythm generation in a mouse model of prenatal infection: implications for schizophrenia. PLoS One 2012; 7:e29754.
79. Pacheco-Lopez G, Giovanoli S, Langhans W, Meyer U: Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia. Schizophr Bull 2013; 39: 319-329.
80. Garbett KA, Hsiao EY, Kalman S, Patterson PH, Mirnics K: Effects of maternal immune activation on gene expression patterns in the fetal brain. Transl Psychiatry 2012; 2:e98.
81. Maayan R, Ram E, Biton D, Cohen H, Baharav E, Strous RD: The influence of DHEA pretreatment on prepulse inhibition and the HPA-Axis stress response in rat offspring exposed prenatally to polyriboinosinic-polyribocytidylic-Acid (PIC). Neurosci Lett 2012; 521: 6-10.
82. Ashdown H, Dumont Y, Ng M, Poole S, Boksa P, Luheshi GN: The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry 2006; 11: 47-55.
83. Baharnoori M, Bhardwaj SK, Srivastava LK: Neonatal behavioral changes in rats with gestational exposure to lipopolysaccharide: a prenatal infection model for developmental neuropsychiatric disorders. Schizophr Bull 2012; 38: 444-456.
84. Malkova NV, Yu CZ, Hsiao EY, Moore MJ, Patterson PH: Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun 2012; 26: 607-616.
85. Oskvig DB, Elkahloun AG, Johnson KR, Phillips TM, Herkenham M: Maternal immune activation by LPS selectively alters specific gene expression profiles of interneuron migration and oxidative stress in the fetus without triggering a fetal immune response. Brain Behav Immun 2012; 26: 623-634.
86. Eastwood SL, Harrison PJ: Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis. Mol Psychiatry 2003; 8: 769, 821-831.
87. Glantz LA, Lewis DA: Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000; 57: 65-73.
88. Broadbelt K, Byne W, Jones LB: Evidence for decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. Schizophr Res 2002; 58: 75-81.
89. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS: Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 2000; 97: 8104-8109.
90. Davis KL, Kahn RS, Ko G, Davidson M: Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 1991; 148: 1474-1486.
91. Elvevag B, Goldberg TE: Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol 2000; 14: 1-21.
92. Mohamed S, Paulsen JS, O'Leary D, Arndt S, Andreasen N: Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch Gen Psychiatry 1999; 56: 749-754.
93. Freedman R, Olincy A, Ross RG, Waldo MC, Stevens KE, Adler LE: The genetics of sensory gating deficits in schizophrenia. Curr Psychiatry Rep 2003; 5: 155-161.
94. Bogerts B, Meertz E, Schonfeldt-Bausch R: Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiatry 1985;42:784-791.
95. Arnold OH: Schizophrenia-A disturbance of signal interaction between the entorhinal cortex and the dentate gyrus? The contribution of experimental dibenamine psychosis to the pathogenesis of schizophrenia: a hypothesis. Neuropsychobiology 1999; 40: 21-32.
96. Velakoulis D, Pantelis C, McGorry PD, Dudgeon P, Brewer W, Cook M: Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch Gen Psychiatry 1999; 56: 133-141.
97. Weinberger DR: Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 1999; 45: 395-402.
98. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD: Genome-wide expression analysis reveals dysregulation of myelinationrelated genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001; 98: 4746-4751.
99. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB: Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003; 362: 798-805.
100. Benes FM, Khan Y, Vincent SL, Wickramasinghe R: Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain. Synapse 1996; 22: 338-349.
101. Zhang ZJ, Reynolds GP: A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res 2002; 55: 1-10.
102. Benes FM, Lim B, Matzilevich D, Walsh JP, Subburaju S, Minns M: Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc Natl Acad Sci USA 2007; 104: 10164-10169.
103. van den Buuse M, Garner B, Gogos A, Kusljic S: Importance of animal models in schizophrenia research. Aust NZ J Psychiatry 2005; 39: 550-557.
104. Phillips LJ, McGorry PD, Garner B, Thompson KN, Pantelis C, Wood SJ: Stress, the hippocampus and the hypothalamic-pituitaryadrenal axis: implications for the development of psychotic disorders. Aust NZ J Psychiatry 2006; 40: 725-741.
105. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P: Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 2002; 22: 2718-2729.
106. Arion D, Unger T, Lewis DA, Levitt P, Mirnics K: Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry 2007; 62: 711-721.
107. Martins-de-Souza D, Schmitt A, Roder R, Lebar M, Schneider-Axmann T, Falkai P: Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia. J Psychiatr Res 2010; 44: 989-991.
108. Ryan MC, Collins P, Thakore JH: Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003; 160: 284-289.
109. Thakore JH, Mann JN, Vlahos I, Martin A, Reznek R: Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord 2002; 26: 137-141.
110. Elman I, Borsook D, Lukas SE: Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with secondgeneration antipsychotic agents. Neuropsychopharmacology 2006; 31: 2091-2120.
111. Krause D, Matz J, Weidinger E, Wagner J, Wildenauer A, Obermeier M: The association of infectious agents and schizophrenia. World J Biol Psychiatry 2010; 11: 739-743.